https://www.selleckchem.com/pr....oducts/valproic-acid
The secondary findings in germline variants considered to be associated with hereditary tumors were detected in 9% (15/16 of the patients. Seventeen patients (11%, 17/16 were treated with genotype-matched therapeutic agents, and the response rate was 47% (8/17). The median turnaround time for physicians was 20 days, and the median survival time after the initial visit was 8.7 months. The results of the present study prove the feasibility of implementing in-house clinical sequencing as a promising laboratory examination techniq
Like
Comment
Share
